Delcath Systems (DCTH) Reports Q4 Loss of $0.01/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Delcath Systems (DCTH) Reports Q4 Loss of $0.01/Share

Delcath Announces Second Quarter 2017 Financial Results

August 8, 2017 8:30 AM EDT

NEW YORK, Aug. 8, 2017 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces financial results for the three and six months ended June 30, 2017.

Highlights from the second quarter of 2017 and recent weeks include:

Revenue for the second quarter of 2017 increased 20% to $0.6 million from $0.5 million in the prior-year quarter;  Revenue for the first six months of 2017 increased 44% to $1.3 million from $0.9 million in the prior-year period; Inclusion of CHEMOSAT in Dutch Health Authorities Guidelines (published... More